A 24-week treatment strategy with pegylated interferon/ribavirin in HIV/hepatitis C virus genotype 3-coinfected patients who achieved a rapid virologic response results in a high sustained virologic response rate.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014-01-01 | PMID 24065317
Rivero-Juarez Antonio, López-Cortés Luis F, Camacho Angela and 6 more
